CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome: In particular, the lifetime risk of developing hereditary diffuse gastric cancer (HDGC) and lobular breast cancer (LBC) in CDH1 mutation carriers has been estimated to be 80% and 60% respectively [2].